Publications

Urban JD, Mailman RB. Characterization of the N27 dopaminergic cell line as a model for elucidating the actions of functionally selective dopaminergic ligands. 35th Annual Neuroscience Meeting, Washington, DC, November 2005.

Grasty RC, Roberts N, Klinefelter G, Bjork JA, Wallace KB, Lau CS, Rogers JM. 2005. Effects of prenatal perfluorooctanesulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res A 73:314.

Perry CS, Morton E. Lessons learned from creating integrated Excel models to calculate human health screening values. Society for Risk Analysis Annual Meeting, Palm Springs, CA, December 2004.

Urban JD, Gay EA, Mailman RB. Functional selectivity as a mechanism of action of newer atypical antipsychotic drugs. 34th Annual Neuroscience Meeting, San Diego, CA, October 2004.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. Tissue distribution and elimination of BDE 47 in mice following a single oral dose. Dioxin 2004, Berlin, Germany, September 2004.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. 2004. Perfluorooctane sulfonate (PFOS) alters lung development in the neonatal rat. Birth Defects Res A 70(5)264, Abstract 42; doi: 10.1002/bdra.20026.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. Disposition of 2,2’,4,4’-tetrabromodiphenylether (BDE 47) in female mice. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. Effects of prenatal exposure to perfluorooctane sulfonate on the developing lung in the rat. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Urban JD, Gay EA, Mailman RB. Decreased neurological side-effects with aripiprazole: A result of functional selectivity of the D2 receptor? Society of Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Perry CS. Process for development of protective concentration levels for remediation sites in Texas. Presented at Society for Environmental Toxicology and Chemistry (SETAC) meeting, Austin, TX, November 2003.